Molecular targets for improving arteriovenous fistula maturation and patency

Molecular targets for improving arteriovenous fistula maturation and patency

The increasing prevalence of chronic and end-stage renal disease creates an increased need for reliable vascular access; although arteriovenous fistulae (AVF) are the preferred mode of hemodialysis access, 60% fail to mature and only 50% remain patent at 1 year. Fistulae mature by diameter expansion...

Full description

Bibliographic Details
Main Authors: Jolanta Gorecka, Arash Fereydooni, Luis Gonzalez, Shin Rong Lee, Shirley Liu, Shun Ono, Jianbiao Xu, Jia Liu, Ryosuke Taniguchi, Yutaka Matsubara, Xixiang Gao, Mingjie Gao, John T Langford, Bogdan Yatsula, Alan Dardik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Vascular Investigation and Therapy
Subjects:
arteriovenous fistula
chronic kidney disease
fistula failure
hemodialysis
maturation
Online Access:http://www.vitonline.org/article.asp?issn=2589-9686;year=2019;volume=2;issue=2;spage=33;epage=41;aulast=Gorecka

Internet

http://www.vitonline.org/article.asp?issn=2589-9686;year=2019;volume=2;issue=2;spage=33;epage=41;aulast=Gorecka

Similar Items